On Friday, the Swiss journal FASEB published a study that links synthetic erythropoietin, or EPO, with an increased risk of brain aneurysms. The drug is commonly used by athletes to boost performance in endurance races and is banned by the World Anti-Doping Agency. In the study, even low doses were shown to constrict arteries and decrease blood flow to the brain. "Now we know that folks who use EPO covertly are cheating not only the time-clock, but themselves,” said Gerald Weissmann, M.D., Editor-in-Chief of FASEB.
Read more at FASEB Journal